๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Bioavailability studies with ciglitazone in beagles I. Effect of a meal on the bioavailability of three ciglitazone dosage forms

โœ Scribed by S. R. Cox; E. L. Harrington; R. A. Hill; V. J. Capponi; A. C. Shah


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
566 KB
Volume
6
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

โœฆ Synopsis


Three separate Latin square crossover studies were conducted in beagles to examine the effect of a meal on the bioavailability of a ciglitazone tablet, suspension, and solution. In these studies, drug was administered to fasted animals with either 50ml water or with 180g Purina Dog Chow and 20g butter. The data indicated that the meal significantly increased the AUC by about 40 per cent for both the tablet and the suspension but had no significant effect on the solution treatment. Comparisons across studies indicated low bioavailability in fasted animals from either the tablet or suspension relative to the solution. When drug was co-administered with a meal, however, bioavailability appeared to be independent of dosage form.


๐Ÿ“œ SIMILAR VOLUMES


Bioavailability studies with ciglitazone
โœ Steven R. Cox; Ellen L. Harrington; Vincent J. Capponi ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 414 KB ๐Ÿ‘ 2 views

Bioavailability studies in fasted dogs with ciglitazone (CGZ), an oral hypoglycemic agent, suggested that an absorption window could contribute to the poor oral availability of CGZ. If so, propantheline bromide (PPB) could increase the residence time of CGZ at absorption sites and increase its bioav

Allopurinol: A comparative study of the
โœ Poul Nissen; Linda Pedersen ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 268 KB ๐Ÿ‘ 2 views

A comparative bioavailability study was carried out with two allopurinol products, i.e. Allopurinol tablets 100 mg, DAK, and ApurinB tablets 100 mg, Gea. Eleven healthy volunteers participated and were given a single dose of 200 mg of each product according to the cross-over principle. The bioavaila